Home Coronavirus About Us     History     Ethic and Integrity     Mission and Values     Industrial Operations     Executive Committee of Brazil     Annual Report     We are B Corp     Company Information - Brazil and Globally Manivasc Contacts Therapeutic Areas      Respiratória      Neonatologia      Cardiovascular      Doenças Raras      Suplementos Alimentares      Produtos
  • Health professionals
  • Your Health     Apnea of Prematurity     Asthma     COPD     Hypertension     Rhinitis     Respiratory Distress Syndrome (RDS)     Thalassemia     Acessar Program     Popular Pharmacy Program     The portrait of COPD from the view of brazilians Inhalation devices Pharmacovigilance Pipeline and New Business     Pipeline     New business     Clinical Research Corporate Responsibility     Chiesi foundation     HSE     Programs     Community Support Sustainability     Sustainability at Chiesi     We ACT – Sustainability Manifesto     Ethics     Transparency     People at the Center     Environment      Supply Chain Sustainability     Community     Chiesi Foundation     SGEH – Energy and Water Policy     Transparency and Equal Pay Report Work with us Press     News     Press Releases     Acknowledgments     Press Contact
  • Health professionals
    • Home
    • |
    • Contacts
    • |
    • Health professionals
    • |
    • Pharmacovigilance
    • |
    • Chiesi Group
    • BR
    • EN
    Welcome to Chiesi
    Brazil
    Digite ao menos 3 caracteres
    • About Us
      • History
      • Ethic and Integrity
      • Mission and Values
      • Industrial Operations
      • Executive Committee of Brazil
      • Annual Report
      • We are B Corp
      • Company Information - Brazil and Globally
    • Therapeutic Areas
      • Respiratory
      • Neonatology
      • Cardiovascular
      • Rare diseases
      • OTC
      • Products
    • Your Health
      • Apnea of Prematurity
      • Asthma
      • COPD
      • Hypertension
      • Rhinitis
      • Respiratory Distress Syndrome (RDS)
      • Thalassemia
      • Acessar Program
      • Popular Pharmacy Program
      • The portrait of COPD from the view of brazilians
      • Inhalation devices
    • Pipeline and New Business
      • Pipeline
      • New business
      • Clinical Research
    • Corporate Responsibility
      • Chiesi foundation
      • HSE
      • Programs
      • Community Support
    • Sustainability
      • Sustainability at Chiesi
      • We ACT – Sustainability Manifesto
      • Ethics
      • Transparency
      • People at the Center
      • Environment
      • Supply Chain Sustainability
      • Community
      • Chiesi Foundation
      • SGEH – Energy and Water Policy
      • Transparency and Equal Pay Report
    • Work with us
    • Press
      • News
      • Press Releases
      • Acknowledgments
      • Press Contact
    • Health professionals
    • slidebg1
    • slidebg1
    • slidebg1
    • slidebg1
    • slidebg1
    • slidebg1
    • slidebg1
    • slidebg1
    • slidebg1
    • slidebg1
    • slidebg1
    • Respiratory
      Chiesi Pharmaceuticals is fully committed to improving the quality of life of people suffering...
      Respiratory
      Chiesi Pharmaceuticals is fully committed to improving the quality of life of people suffering...
    • Neonatology
      For decades, Chiesi Pharmaceuticals has been committed to neonatology, working alongside the...
      Neonatology
      For decades, Chiesi Pharmaceuticals has been committed to neonatology, working alongside the...
    • Cardiovascular
      Cardiovascular diseases are the leading cause of death in the world: more people die annually...
      Cardiovascular
      Cardiovascular diseases are the leading cause of death in the world: more people die annually...
    • Rare diseases
      The term rare applies to diseases that affect a limited number of people, with prevalence below...
      Rare diseases
      The term rare applies to diseases that affect a limited number of people, with prevalence below...
    • OTC
      Over The Counter drugs (OTC) are those that do not require a prescription for purchase.
      OTC
      Over The Counter drugs (OTC) are those that do not require a prescription for purchase.
    • Products
        Chiesi...
      Products
        Chiesi...
    27
    08/24
    NEWS
    Chiesi Brasil está entre as melhores empresas para trabalhar no setor de...
    São Paulo, 27 agosto de 2024 – A Chiesi Brasil comemora...
    Search all the news
    © 2025 Chiesi Farmacêutica Ltda
    Dr. Rubens Gomes Bueno Street, 691
    14º Floor
    Várzea de Baixo
    São Paulo/SP
    ZIP Code 04730-000
    Phone: +55 11 3095-2300
    CNPJ: 61.363.032/0010-37

    • Site map
    • Chiesi worldwide
    • Terms of use
    • Privacy Policy
    • Facebook Terms of Use
    • SpeakUp&BeHeard - Complaints Channel
    • Customer Service
    • Credits
    CHIESI ON THE WEB
    CHIESI ON THE WEB
    Áustria
    Chiesi Pharmaceuticals GmbH
    Bélgica
    Chiesi sa
    Brasil
    Chiesi Farmacêutica Ltda
    Bulgária
    Chiesi Bulgaria Ltd.
    China
    Chiesi Pharmaceutical (Shanghai) Co., Ltd
    República Tcheca
    Chiesi CZ s.r.o.
    França
    Chiesi S.A.
    Alemanha
    Chiesi GmbH
    Grécia
    Chiesi Hellas Pharmaceuticals S.A.
    Hungria
    Chiesi Hungary Kft.
    Itália
    -
    México
    Chiesi Mexico S.A. de C.V.
    Paquistão
    Chiesi Pharmaceuticals (Pvt) Limited
    Polônia
    Chiesi Polonia
    Romênia
    Chiesi România S.r.l.
    Rússia
    Chiesi Pharmaceuticals LLC
    República Eslovaca
    Chiesi Slovakia s.r.o
    Eslovênia
    Chiesi Slovenija, d.o.o
    Espanha
    Chiesi España S.A.
    Suécia
    Chiesi Pharma AB
    Holanda
    Chiesi Pharmaceuticals B.V.
    Turquia
    Chiesi İlaçTicaret Limited Sirketi  A.Ş.
    Reino Unido
    Chiesi Ltd
    Estados Unidos
    Chiesi Usa Inc.